ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ·Healthcare·Biotechnology
$21.15
-1.12%
Mkt Cap $3.66B
Analyst Ratings
Buy
11
Hold
1
Sell
0
Price Target (60 analysts)
$34.78
Range $29.00 – $40.00
Implied Upside
+64.4%
Consensus $34.78 vs current $21.15
NASDAQ·Healthcare·Biotechnology
$21.15
-1.12%
Mkt Cap $3.66B
Buy
11
Hold
1
Sell
0
Price Target (60 analysts)
$34.78
Range $29.00 – $40.00
+64.4%
Consensus $34.78 vs current $21.15